Marwan Mikheal Azar, MD, FAST, FIDSA
Associate Professor AdjunctDownloadHi-Res Photo
Cards
Additional Titles
Infectious Disease Fellowship Program Director, Internal Medicine
About
Titles
Associate Professor Adjunct
Infectious Disease Fellowship Program Director, Internal Medicine
Biography
Dr. Azar obtained his medical degree from the American University of Beirut in Lebanon. He then completed a post-doctoral research fellowship at Yale followed by Internal Medicine Residency at Indiana University. He is trained in both Infectious Diseases (Yale) and Clinical Microbiology (Massachusetts General Hospital) with a focus on infections in the immunocompromised host and clinical mycology.
Appointments
Laboratory Medicine
Associate Professor on TermSecondary
Other Departments & Organizations
Education & Training
- Clinical Microbiology Fellowship
- Massachusetts General Hospital, Harvard University (2017)
- Infectious Diseases Fellowship
- Yale University (2016)
- Internal Medicine Residency
- Indiana University (2014)
- Post-doctoral Research Fellowship
- Yale University (2011)
- MD
- American University of Beirut (2009)
- BS
- American University of Beirut, Biology (2005)
Board Certifications
Medical Microbiology
- Certification Organization
- AB of Pathology
- Latest Certification Date
- 2024
- Original Certification Date
- 2017
Infectious Disease
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2016
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2014
Research
Overview
Medical Research Interests
Diagnostic Errors; Diseases; Immunocompromised Host; Invasive Fungal Infections; Organisms
ORCID
0000-0001-5498-5042
Research at a Glance
Yale Co-Authors
Frequent collaborators of Marwan Mikheal Azar's published research.
Publications Timeline
A big-picture view of Marwan Mikheal Azar's research output by year.
Research Interests
Research topics Marwan Mikheal Azar is interested in exploring.
Frederick Lewis Altice, MD, MA
Sandra Ann Springer, MD
Marie-Louise Landry, MD
Roland Assi, MD, MMS, FACS
Nathan Grubaugh, PhD
Angela Di Paola, PhD
115Publications
3,755Citations
Immunocompromised Host
Invasive Fungal Infections
Publications
2024
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient
Marvin J, Trubin P, Azar M. Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient. Transplant Infectious Disease 2024, 26: e14329. PMID: 38971997, DOI: 10.1111/tid.14329.Peer-Reviewed Original ResearchCitationsA Patient With Type 1 Diabetes and Acute Rhinosinusitis
Roman F, Azar M, Trubin P. A Patient With Type 1 Diabetes and Acute Rhinosinusitis. JAMA 2024, 331: 1586-1587. PMID: 38630502, DOI: 10.1001/jama.2024.0642.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsAtypical pneumonia testing in transplant recipients
Feller F, Trubin P, Malinis M, Vogel J, Merwede J, Peaper D, Azar M. Atypical pneumonia testing in transplant recipients. Transplant Infectious Disease 2024, 26: e14256. PMID: 38430482, DOI: 10.1111/tid.14256.Peer-Reviewed Original ResearchAltmetricConceptsHematopoietic stem cell transplantationTransplant recipientsPathogens of pneumoniaAtypical pneumoniaAugmented immunosuppressionAtypical pathogensTest positivity rateChimeric antigen receptor T cellsHematopoietic stem cell transplant recipientsDiagnosis of atypical pneumoniaPositive rateCases of mycoplasma infectionStem cell transplantationSolid organ transplantationRetrospective cohort studyMycoplasma infectionImmunocompromised patientsCell transplantationAnalysis of diagnostic testsDiagnostic yieldTransplant cohortPost-transplantationT cellsCohort studyRates of testingLarone’s Medically Important Fungi: A Guide to Identification, 7 Edition - Volume 30, Number 3—March 2024 - Emerging Infectious Diseases journal - CDC
Azar M. Larone’s Medically Important Fungi: A Guide to Identification, 7 Edition - Volume 30, Number 3—March 2024 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2024, 30: 625-626. PMCID: PMC10902529, DOI: 10.3201/eid3003.231623.Peer-Reviewed Original ResearchCitationsAltmetricConceptsLung infections due to emerging fungal pathogens
Roman F, Pischel L, Azar M. Lung infections due to emerging fungal pathogens. Current Opinion In Pulmonary Medicine 2024, 30: 258-265. PMID: 38411158, DOI: 10.1097/mcp.0000000000001059.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsEndemic mycosesManagement of pulmonary infectionsFungal pathogensPathogenic fungiAntifungal prophylaxisBlastomyces speciesFungal infectionsFungal organismsAspergillus moldsEnvironmental changesImmunocompromised hostsPulmonary infectionTherapeutic challengeLung infectionMycosesClinical evidenceClinical managementIncreased incidencePulmonary diseaseEnlarged poolDisease burdenInfectionLomentosporaScedosporiumDiagnostic capabilitiesClinical outcomes of SARS‐CoV‐2 infection in kidney transplant recipients on belatacept: a single‐center experience
Feller F, Azar M, Marvin J, Cohen E, Virmani S, Malinis M. Clinical outcomes of SARS‐CoV‐2 infection in kidney transplant recipients on belatacept: a single‐center experience. Transplant Infectious Disease 2024, 26: e14253. PMID: 38351494, DOI: 10.1111/tid.14253.Peer-Reviewed Original ResearchAltmetricThe respiratory syncytial virus vaccines are here: Implications for solid organ transplantation
Trubin P, Azar M, Kotton C. The respiratory syncytial virus vaccines are here: Implications for solid organ transplantation. American Journal Of Transplantation 2024, 24: 897-904. PMID: 38341028, DOI: 10.1016/j.ajt.2024.02.003.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRespiratory syncytial virusSolid organ transplantationLower respiratory tract diseaseHigh risk of infectious complicationsBurden of RSV diseaseOrgan transplantationRisk of infectious complicationsRespiratory syncytial virus vaccineRespiratory tract diseaseCenters for Disease Control and Prevention's Advisory CommitteeOrgan transplant recipientsSolid organ recipientsPoor clinical outcomesFood and Drug AdministrationRSV F glycoproteinRespiratory virus vaccinesRSV diseaseInfectious complicationsTransplant recipientsClinical outcomesSyncytial virusClinical decision-makingImmunocompromised individualsOrgan recipientsImmunization PracticesClinical outcomes of baloxavir versus oseltamivir in immunocompromised patients
Ringer M, Malinis M, McManus D, Davis M, Shah S, Trubin P, Topal J, Azar M. Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients. Transplant Infectious Disease 2024, 26: e14249. PMID: 38319665, DOI: 10.1111/tid.14249.Peer-Reviewed Original ResearchCitationsAltmetricConceptsLength of stayIntensive care unitBaloxavir groupClinical outcomesSecondary outcomesIntensive care unit length of stayRetrospective study of hospitalized patientsEfficacy of baloxavirResolution of feverImmunocompromised adult patientsStudy of hospitalized patientsRetrospective cohort studyAssociated with longer timeResolution of hypoxiaOseltamivir groupInfluenza subtypesImmunocompromised patientsInfluenza ANo significant differenceMedian timeResistance ratesNeuraminidase inhibitorsRetrospective studyBaseline characteristicsAdult patients
2023
A fast-track to fungal diagnosis: the potential of molecular diagnostics for fungi at the point of care
Trubin P, Azar M. A fast-track to fungal diagnosis: the potential of molecular diagnostics for fungi at the point of care. Expert Review Of Molecular Diagnostics 2023, 24: 143-146. PMID: 37991006, DOI: 10.1080/14737159.2023.2287504.Peer-Reviewed Original ResearchCitationsA Diagnostic Approach to Fungal Pneumonia An Infectious Diseases Perspective
Azar M. A Diagnostic Approach to Fungal Pneumonia An Infectious Diseases Perspective. CHEST Journal 2023, 165: 559-572. PMID: 37813181, DOI: 10.1016/j.chest.2023.10.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricConceptsFungal pneumoniaAppropriate diagnostic testingClinical syndromeDiagnostic testingLower respiratory tract infectionsNon-resolving pneumoniaRespiratory tract infectionsInfectious diseases perspectiveTract infectionsRadiographic patternsCommon causeEpidemiologic exposuresCorrect diagnosisRisk populationsPneumoniaDiagnostic approachHost factorsDisease perspectiveConstellation of factorsPatientsSyndromeInfectionEpidemiologyIncidenceDiagnosis
Clinical Trials
Current Trials
Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study
HIC ID2000030204RoleSub InvestigatorPrimary Completion Date03/31/2031Recruiting ParticipantsGenderBothAge18+ yearsHOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
HIC ID2000025220RoleSub InvestigatorPrimary Completion Date06/30/2024Recruiting ParticipantsGenderBothAge18+ yearsHOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
HIC ID2000022391RoleSub InvestigatorPrimary Completion Date08/01/2021Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
activity Connecticut Antimicrobial Resistance/Antimicrobial Stewardship Advisory Group
Advisory BoardsCommittee MemberDetailsCT DPH2017 - Presentactivity Diagnostics Committee
Advisory BoardsCommittee MemberDetailsIDSA2018 - Presentactivity M54 document committee
Advisory BoardsCommittee MemberDetailsCLSI2018 - Presentactivity Guideline Committee (Should patients with community-acquired pneumonia undergo PCR-testing for respiratory pathogens other than influenza?”
Advisory BoardsCommittee MemberDetailsATS2018 - Presentactivity Transplant diagnostics committee
Advisory BoardsExecutive Board MemberDetailsAST2018 - Present
News
News
- September 13, 2024Source: Yale Medicine
Are Cold Cuts Safe? What to Know About the Recent Listeria Outbreaks
- May 28, 2024
Unique Case of Mucormycosis Presented in JAMA Clinical Challenge
- February 09, 2024Source: NPR
Coronavirus FAQ: I'm Immunocompromised. Will Pills, Gargles and Sprays Fend Off COVID?
- January 30, 2024
Fostering Equity and Inclusion in Infectious Diseases at Yale
Get In Touch
Contacts
Appointment Number
Clinic Fax Number